FEB 08, 2017 12:25 PM PST

Two B Cells Types, Two Completely Different Life Roles

WRITTEN BY: Kara Marker

A specialized form of immune B cells exist in the human spleen to protect the body from specific types of bacteria. But there is a unique molecular process that needs to happen in order for immature B cells to become these specialized cells over other types of cells.

From The Flanders Institute for Biotechnology (VIB), researchers investigated the pathways behind the differentiation of specialized B cells called MZB cells, named for the marginal zone in the spleen where they congregate. The spleen plays the important role of filtering the blood for bacteria and other foreign particles. 

A  section taken from a spleen reveals splenic tissue with sheets of immune cells. Source: Cytopath Veterinary Pathology Laboratory

MZB cells are involved in antibody “training” to prepare them for the fight against infectious disease, mainly producing antibodies that target encapsulated bacterial like pneumococcus. However, MZB cells are not the only immune cells doing work in the spleen. They share some space with another B cell subtype called follicular B cells, so what makes precursor cells “decide” to become MZB cells versus follicular B cells?

"We had a 'eureka!' moment after discovering that a little-known protein, Taok3, brings a certain proteinase, ADAM10, to the surface of the immature B cell that triggers its development into an MZB cell,” explained VIB’s Hamida Hammad. “Without that special event, immature B cells can only develop into follicular B cells." Hammad and the team from VIB started their study with the knowledge that Taok3 protein triggers, somehow, the development of MZB cells.

Identifying the role of Taok3 protein in the development of MZB cells provides new possibilities for treatments of genetic conditions, asthma, and diabetes, which might rely on the immune response which includes MZB cells.

VIB researchers confirmed the role of Taok3 in mice studies by removing the Taok3 gene. Without it, the mice would make almost any B cell type except MZB cells. They were also especially susceptible to respiratory infection from pneumococcus bacteria.

"With an abundance of only follicular B cells, Taok3-free mice are less capable of fighting these types of bacteria effectively,” Hammad said.

“This research has generated insights that are very relevant to new therapies to a range of important diseases,” said VIB’s Bart Lambrecht. “It goes to show that basic science sometimes leads to unexpected - and important - applications."

The VIB’s new study was published in the journal Nature Immunology.

Source: The Flanders Institute for Biotechnology (VIB)

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 07, 2019
Immunology
JUL 07, 2019
Are Bacteria Fighting Cancer For Us?
Scientists at the Sanford Burnham Prebys Medical Discovery Institute found that the RNF5 enzyme, produced by a gene in gut microbes affects tumor growth.&n...
AUG 13, 2019
Health & Medicine
AUG 13, 2019
Blood-Brain Barrier Impairment and Its Role in Alzheimer's Disease
In healthy people, the blood-brain barrier (BBB), which is fromed by brain endothelial cells, strictly controls the entrance of harmful materials into...
SEP 11, 2019
Health & Medicine
SEP 11, 2019
Diagnosis and Treatment of Neurosarcoidosis
Sarcoidosis is a multisystem inflammatory disease characterized by the formation of non-caseating granulomas in the affected organs. The majority of p...
SEP 29, 2019
Drug Discovery & Development
SEP 29, 2019
Researchers Can Now Reverse Skin Cancer
Ten years ago, just 5% of people with advanced melanoma (skin cancer) lived more than five years after being diagnosed. Now however, researchers from the I...
JAN 16, 2020
Health & Medicine
JAN 16, 2020
Babies in Africa Receive World's First Malaria Vaccine
Would you accept a vaccine that was only 40% effective? For those at risk of malaria, the answer is likely a resounding, "yes!" According to the...
FEB 10, 2020
Immunology
FEB 10, 2020
Measles infections can give the immune system amnesia
The immune system detects the presence of invading microbes that it recognizes from previous infections, and initiates a full-blown immune response. New re...
Loading Comments...